Missed Nvidia? Buy Elon Musk’s “Silent Partner”

In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.

So please click here to see the details because a lot of people could get rich.

R. Hoover Biography and Net Worth

Director of Elanco Animal Health

R. David Hoover is the Chairman of the Elanco Board of Directors. He retired from Ball Corporation as chief executive officer in 2011 after more than 40 years of service. He retired as chairman of the board of directors in 2013 and continues to serve as a director. After joining Ball Corporation in 1970, Hoover held several leadership positions throughout his tenure, including vice president of finance and administration for both the company’s agricultural systems division and the company’s aerospace systems group; vice president and treasurer; senior vice president and chief financial officer; chief operating officer and more.

Hoover is a member of the boards of Ball Corporation and Edgewell Personal Care Company. Previously he served on the boards of the National Association of Manufacturers, the Irwin Financial Corporation, Qwest International, Inc., and Steelcase, Inc., as well as chair of the board of governors of the Can Manufacturers Institute.

Hoover is a member and past chair of the board of trustees of DePauw University and on the Indiana University Kelley School of Business Dean’s Council. He is also a director of Children’s Hospital Colorado, and a member of the Colorado Forum. He received his bachelor’s degree in economics from DePauw University and his M.B.A. in finance and real estate from Indiana University. Additionally, he completed the advanced management program at Harvard University Graduate School of Business.

What is R. David Hoover's net worth?: The estimated net worth of R. David Hoover is at least $2.15 million as of March 6th, 2024. Mr. Hoover owns 185,000 shares of Elanco Animal Health stock worth more than $2,151,550 as of December 21st. This net worth estimate does not reflect any other assets that Mr. Hoover may own. Learn More about R. David Hoover's net worth.
How do I contact R. David Hoover?: The corporate mailing address for Mr. Hoover and other Elanco Animal Health executives is 2500 INNOVATION WAY, GREENFIELD IN, 46140. Elanco Animal Health can also be reached via phone at (877) 352-6261 and via email at [email protected]. Learn More on R. David Hoover's contact information.
Has R. David Hoover been buying or selling shares of Elanco Animal Health?: R. David Hoover has not been actively trading shares of Elanco Animal Health within the last three months. Most recently, on Wednesday, March 6th, R David Hoover bought 20,000 shares of Elanco Animal Health stock. The stock was acquired at an average cost of $16.14 per share, with a total value of $322,800.00. Following the completion of the transaction, the director now directly owns 185,000 shares of the company's stock, valued at $2,985,900. Learn More on R. David Hoover's trading history.
Who are Elanco Animal Health's active insiders?: Elanco Animal Health's insider roster includes John Bilbrey (Director), Art Garcia (Director), Michael Harrington (Director), R. Hoover (Director), Rajeev Modi (Insider), Jeffrey Simmons (President & CEO), and Todd Young (Insider). Learn More on Elanco Animal Health's active insiders.
Are insiders buying or selling shares of Elanco Animal Health?: During the last year, Elanco Animal Health insiders bought shares 4 times. They purchased a total of 138,500 shares worth more than $1,930,475.00. The most recent insider tranaction occured on August, 22nd when Director Michael J Harrington bought 3,500 shares worth more than $51,975.00. Insiders at Elanco Animal Health own 0.6% of the company. Learn More about insider trades at Elanco Animal Health.
Information on this page was last updated on 8/22/2024.

R. David Hoover Insider Trading History at Elanco Animal Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/6/2024	Buy	20,000	$16.14	$322,800.00	185,000
3/3/2023	Buy	10,000	$11.13	$111,300.00	155,000
9/9/2022	Buy	20,000	$15.18	$303,600.00	145,000
5/20/2022	Buy	10,000	$23.33	$233,300.00	125,000
3/1/2022	Buy	5,000	$28.66	$143,300.00
11/30/2021	Buy	10,000	$29.38	$293,800.00
11/15/2021	Buy	5,000	$31.79	$158,950.00
5/11/2021	Buy	25,000	$32.44	$811,000.00	41,960
8/28/2020	Buy	10,000	$28.43	$284,300.00	36,075
8/21/2020	Buy	10,000	$26.94	$269,400.00	31,075
3/2/2020	Buy	3,900	$27.40	$106,860.00	21,075
2/28/2020	Buy	4,100	$26.99	$110,659.00	21,075
8/22/2019	Buy	15,000	$26.96	$404,400.00
3/13/2019	Buy	20,000	$31.43	$628,600.00

R. David Hoover Buying and Selling Activity at Elanco Animal Health

Elanco Animal Health Company Overview

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Today's Range

Now: $11.63

$11.63

$12.19

50 Day Range

MA: $12.96

$11.63

$14.50

2 Week Range

Now: $11.63

$11.40

$18.80

Volume

9,435,554 shs

Average Volume

4,797,913 shs

Market Capitalization

$5.75 billion

P/E Ratio

29.08

Dividend Yield

N/A

Beta

1.41